BiotechTube
Gemelli Biotech

Gemelli Biotech

San Diego, United States· Est.
gemellibiotech.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.8M

Overview

Gemelli Biotech is a commercial-stage diagnostics company focused on the high-prevalence gastrointestinal disease market. Its core assets are two direct-to-consumer/physician at-home test kits: Trio-Smart, a 3-gas breath test for Small Intestinal Bacterial Overgrowth (SIBO) and related disorders, and IBS-Smart, a blood test for post-infectious IBS. The company has established clinical validation through academic partnerships and is positioned to capitalize on the growing demand for convenient, specialized diagnostic solutions in gastroenterology.

Gastroenterology

Technology Platform

Application of validated microbiome (fermented gas) and immunology (autoantibody) biomarkers to at-home, non-invasive diagnostic test formats (breath analysis and capillary blood immunoassay).

Funding History

1
Total raised:$2.8M
Seed$2.8M

Opportunities

The large and underserved patient population with chronic GI symptoms represents a major growth opportunity, driven by increasing awareness of SIBO and PI-IBS.
The expansion of telehealth and demand for convenient at-home diagnostics creates a favorable market trend for Gemelli's direct-to-consumer model.

Risk Factors

Key risks include dependence on a limited product portfolio, the challenge of changing physician behavior and securing insurance reimbursement, and potential regulatory evolution for laboratory-developed tests.
Competition from other diagnostic companies and new scientific findings could also impact market position.

Competitive Landscape

Gemelli competes with other SIBO breath test providers (e.g., Quintron, Commonwealth Diagnostics) but differentiates with its 3-gas measurement and strong DTC focus. For PI-IBS, it holds a near-monopoly on the specific antibody test. Broader competition includes traditional diagnostic labs and emerging digital health companies in the GI space.

More companies in Diagnostics & Precision Medicine →More companies in United States →